(HealthDay)—A Medicare Bundled Payments for Care Improvement (BPCI) initiative does not reduce readmission rates or costs among patients with acute exacerbation of chronic obstructive pulmonary disease (COPD), according ...
May 10, 2017
0
1
(HealthDay)—Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) might play an important role in the prevention and treatment of emphysema, according to a study published in the May ...
May 8, 2017
0
0
Better medical responses to the accidental or intentional release of inhaled toxic chemicals are being developed, but the field faces considerable challenges, according to a new report by an international panel of experts.
Apr 21, 2017
0
0
(HealthDay)—A questionnaire-based approach seems to be valid for identifying adults in the intensive care unit with a frailty phenotype, according to a study published online March 30 in the Annals of the American Thoracic ...
Apr 11, 2017
0
0
(HealthDay)—Cardiopulmonary exercise testing, unless contraindicated, should be performed to obtain an overall view of cardiac and pulmonary patients' clinical status, according to a review published online March 31 in ...
Apr 10, 2017
0
0
(HealthDay)—For patients with asthma, serum periostin is useful for detecting chronic rhinosinusitis with nasal polyps, according to a study published online March 1 in the Annals of the American Thoracic Society.
Mar 21, 2017
0
0
(HealthDay)—Use of angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) is associated with slowed progression of percent emphysema on chest computed tomography (CT), according to a study ...
Mar 17, 2017
0
1
(HealthDay)—For patients in septic shock, thiamine is associated with a lower rate of progression to renal replacement therapy (RRT), according to research published online Feb. 16 in the Annals of the American Thoracic ...
Mar 16, 2017
0
0
Since 2000, the last year the American Thoracic Society issued a statement on the effect of air pollution on lung diseases, a growing body of research reveals links between air pollutants and other illnesses, including heart ...
Mar 6, 2017
0
3
Preterm babies given the monoclonal antibody palivizumab to prevent respiratory syncytial virus (RSV) also appear less likely to develop recurrent wheeze, at least until the age of six, according to new research published ...
Feb 3, 2017
0
62
